

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 6.59844850 |
| 2 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.53020635 |
| 3 | endocrine pancreas development (GO:0031018) | 5.31500885 |
| 4 | cellular potassium ion homeostasis (GO:0030007) | 5.06973449 |
| 5 | axon ensheathment in central nervous system (GO:0032291) | 5.06907934 |
| 6 | central nervous system myelination (GO:0022010) | 5.06907934 |
| 7 | sodium ion export (GO:0071436) | 4.98939771 |
| 8 | L-amino acid import (GO:0043092) | 4.98398075 |
| 9 | amino acid import (GO:0043090) | 4.75755982 |
| 10 | * postsynaptic membrane organization (GO:0001941) | 4.53576182 |
| 11 | positive regulation of hormone metabolic process (GO:0032352) | 4.51068683 |
| 12 | glandular epithelial cell differentiation (GO:0002067) | 4.48235617 |
| 13 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 4.45340443 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.44447448 |
| 15 | positive regulation of cellular amine metabolic process (GO:0033240) | 4.37649756 |
| 16 | locomotory exploration behavior (GO:0035641) | 4.16808661 |
| 17 | * presynaptic membrane assembly (GO:0097105) | 4.11065045 |
| 18 | potassium ion import (GO:0010107) | 4.10893364 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.06395127 |
| 20 | vocalization behavior (GO:0071625) | 4.06293899 |
| 21 | negative regulation of osteoblast proliferation (GO:0033689) | 3.95145576 |
| 22 | potassium ion homeostasis (GO:0055075) | 3.91279589 |
| 23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.86529275 |
| 24 | cell communication by electrical coupling (GO:0010644) | 3.85657775 |
| 25 | * presynaptic membrane organization (GO:0097090) | 3.77403103 |
| 26 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.77044443 |
| 27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.70647491 |
| 28 | respiratory chain complex IV assembly (GO:0008535) | 3.68272683 |
| 29 | synaptic vesicle maturation (GO:0016188) | 3.67718013 |
| 30 | nucleotide transmembrane transport (GO:1901679) | 3.66827137 |
| 31 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.66488254 |
| 32 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.66488254 |
| 33 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.63471350 |
| 34 | protein maturation by protein folding (GO:0022417) | 3.61844868 |
| 35 | peptide hormone processing (GO:0016486) | 3.61822804 |
| 36 | GDP-mannose metabolic process (GO:0019673) | 3.58861270 |
| 37 | neurotransmitter uptake (GO:0001504) | 3.57022148 |
| 38 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.56829320 |
| 39 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.56285989 |
| 40 | mannosylation (GO:0097502) | 3.53225365 |
| 41 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.50263371 |
| 42 | cellular sodium ion homeostasis (GO:0006883) | 3.48646846 |
| 43 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.48249872 |
| 44 | exploration behavior (GO:0035640) | 3.43673440 |
| 45 | cerebellar granule cell differentiation (GO:0021707) | 3.42356334 |
| 46 | neuronal action potential propagation (GO:0019227) | 3.39678881 |
| 47 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.39482001 |
| 48 | glutamate secretion (GO:0014047) | 3.36649548 |
| 49 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.34968680 |
| 50 | sequestering of metal ion (GO:0051238) | 3.34595853 |
| 51 | nucleoside diphosphate catabolic process (GO:0009134) | 3.32781478 |
| 52 | cornea development in camera-type eye (GO:0061303) | 3.26455793 |
| 53 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.26268980 |
| 54 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.25777812 |
| 55 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.23497761 |
| 56 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.23365629 |
| 57 | photoreceptor cell maintenance (GO:0045494) | 3.23296220 |
| 58 | astrocyte differentiation (GO:0048708) | 3.22614460 |
| 59 | astrocyte development (GO:0014002) | 3.20827526 |
| 60 | androgen biosynthetic process (GO:0006702) | 3.20465660 |
| 61 | layer formation in cerebral cortex (GO:0021819) | 3.20293161 |
| 62 | neuronal ion channel clustering (GO:0045161) | 3.19590601 |
| 63 | photoreceptor cell differentiation (GO:0046530) | 3.17300825 |
| 64 | eye photoreceptor cell differentiation (GO:0001754) | 3.17300825 |
| 65 | positive regulation of protein kinase C signaling (GO:0090037) | 3.14577997 |
| 66 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.13144354 |
| 67 | facial nerve structural organization (GO:0021612) | 3.12949684 |
| 68 | negative regulation of myotube differentiation (GO:0010832) | 3.11859445 |
| 69 | dermatan sulfate biosynthetic process (GO:0030208) | 3.10744210 |
| 70 | nephron tubule formation (GO:0072079) | 3.08003502 |
| 71 | magnesium ion transport (GO:0015693) | 3.07324473 |
| 72 | cytochrome complex assembly (GO:0017004) | 3.06572812 |
| 73 | neuromuscular process controlling balance (GO:0050885) | 3.05115163 |
| 74 | myelination in peripheral nervous system (GO:0022011) | 3.04346666 |
| 75 | peripheral nervous system axon ensheathment (GO:0032292) | 3.04346666 |
| 76 | photoreceptor cell development (GO:0042461) | 3.03870560 |
| 77 | regulation of pigment cell differentiation (GO:0050932) | 3.03424712 |
| 78 | synaptic vesicle exocytosis (GO:0016079) | 3.02484536 |
| 79 | acidic amino acid transport (GO:0015800) | 3.01614000 |
| 80 | GMP metabolic process (GO:0046037) | 3.01206135 |
| 81 | regulation of synaptic vesicle transport (GO:1902803) | 3.00594793 |
| 82 | metanephric nephron tubule development (GO:0072234) | 3.00034760 |
| 83 | metanephric tubule development (GO:0072170) | 3.00034760 |
| 84 | eye photoreceptor cell development (GO:0042462) | 2.99606505 |
| 85 | negative regulation of norepinephrine secretion (GO:0010700) | 2.98851103 |
| 86 | positive regulation of insulin secretion (GO:0032024) | 2.97440276 |
| 87 | regulation of glucokinase activity (GO:0033131) | 2.96728637 |
| 88 | regulation of hexokinase activity (GO:1903299) | 2.96728637 |
| 89 | protein localization to synapse (GO:0035418) | 2.95897936 |
| 90 | cell differentiation involved in metanephros development (GO:0072202) | 2.95798460 |
| 91 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.95691492 |
| 92 | cell communication involved in cardiac conduction (GO:0086065) | 2.94973626 |
| 93 | omega-hydroxylase P450 pathway (GO:0097267) | 2.94744098 |
| 94 | response to auditory stimulus (GO:0010996) | 2.93845076 |
| 95 | retinal rod cell development (GO:0046548) | 2.93415836 |
| 96 | pattern specification involved in kidney development (GO:0061004) | 2.93060453 |
| 97 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.92852799 |
| 98 | glandular epithelial cell development (GO:0002068) | 2.92045897 |
| 99 | glycoside metabolic process (GO:0016137) | 2.91793103 |
| 100 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90356181 |
| 101 | auditory behavior (GO:0031223) | 2.90118949 |
| 102 | prenylation (GO:0097354) | 2.90096346 |
| 103 | protein prenylation (GO:0018342) | 2.90096346 |
| 104 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.89982771 |
| 105 | cranial nerve morphogenesis (GO:0021602) | 2.87627598 |
| 106 | nephron epithelium development (GO:0072009) | 2.86703853 |
| 107 | C-terminal protein lipidation (GO:0006501) | 2.85953887 |
| 108 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.84853825 |
| 109 | epithelial cell fate commitment (GO:0072148) | 2.84206204 |
| 110 | dermatan sulfate metabolic process (GO:0030205) | 2.83105337 |
| 111 | myelination (GO:0042552) | 2.82571923 |
| 112 | regulation of timing of cell differentiation (GO:0048505) | 2.82410951 |
| 113 | GPI anchor biosynthetic process (GO:0006506) | 2.82253259 |
| 114 | intraciliary transport (GO:0042073) | 2.81222614 |
| 115 | neuron recognition (GO:0008038) | 2.81216719 |
| 116 | regulation of synapse structural plasticity (GO:0051823) | 2.80056887 |
| 117 | protein localization to Golgi apparatus (GO:0034067) | 2.79288180 |
| 118 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.75915063 |
| 119 | exocrine pancreas development (GO:0031017) | 2.75676004 |
| 120 | toxin metabolic process (GO:0009404) | 2.75675140 |
| 121 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.74637501 |
| 122 | axonal fasciculation (GO:0007413) | 2.74027052 |
| 123 | L-glutamate transport (GO:0015813) | 2.73104211 |
| 124 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.72694135 |
| 125 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.72694135 |
| 126 | axon ensheathment (GO:0008366) | 2.72675596 |
| 127 | ensheathment of neurons (GO:0007272) | 2.72675596 |
| 128 | auditory receptor cell differentiation (GO:0042491) | 2.70834414 |
| 129 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.70128866 |
| 130 | regulation of oxidative phosphorylation (GO:0002082) | 2.69824587 |
| 131 | synaptic transmission, glutamatergic (GO:0035249) | 2.69236959 |
| 132 | cranial nerve development (GO:0021545) | 2.68795929 |
| 133 | notochord development (GO:0030903) | 2.68536190 |
| 134 | type B pancreatic cell development (GO:0003323) | 2.68328247 |
| 135 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.68098972 |
| 136 | mechanosensory behavior (GO:0007638) | 2.65897313 |
| 137 | metanephric nephron epithelium development (GO:0072243) | 2.64981089 |
| 138 | chondroitin sulfate catabolic process (GO:0030207) | 2.63637782 |
| 139 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.63008021 |
| 140 | ER overload response (GO:0006983) | 2.62917695 |
| 141 | renal tubule development (GO:0061326) | 2.62560068 |
| 142 | neurotransmitter secretion (GO:0007269) | 2.61572238 |
| 143 | regulation of respiratory system process (GO:0044065) | 2.61483621 |
| 144 | positive regulation of protein sumoylation (GO:0033235) | 2.60424007 |
| 145 | C4-dicarboxylate transport (GO:0015740) | 2.59880717 |
| 146 | cerebellar Purkinje cell layer development (GO:0021680) | 2.59621410 |
| 147 | apical protein localization (GO:0045176) | 2.59599956 |
| 148 | endothelium development (GO:0003158) | 2.59062060 |
| 149 | oligodendrocyte differentiation (GO:0048709) | 2.58911995 |
| 150 | metanephric epithelium development (GO:0072207) | 2.58694643 |
| 151 | positive regulation of glycolytic process (GO:0045821) | 2.58284879 |
| 152 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 2.58146616 |
| 153 | sphingoid metabolic process (GO:0046519) | 2.58012078 |
| 154 | glycosphingolipid catabolic process (GO:0046479) | 2.56412365 |
| 155 | GPI anchor metabolic process (GO:0006505) | 2.56275986 |
| 156 | negative regulation of astrocyte differentiation (GO:0048712) | 2.53917271 |
| 157 | nephron tubule development (GO:0072080) | 2.53472233 |
| 158 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.52509090 |
| 159 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.51850262 |
| 160 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.51457002 |
| 161 | regulation of development, heterochronic (GO:0040034) | 2.51319762 |
| 162 | positive regulation of dendritic spine development (GO:0060999) | 2.51256752 |
| 163 | cGMP-mediated signaling (GO:0019934) | 2.51151093 |
| 164 | Golgi transport vesicle coating (GO:0048200) | 2.50424686 |
| 165 | COPI coating of Golgi vesicle (GO:0048205) | 2.50424686 |
| 166 | cranial nerve structural organization (GO:0021604) | 2.50386408 |
| 167 | pharyngeal system development (GO:0060037) | 2.50344037 |
| 168 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50155373 |
| 169 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.48432308 |
| 170 | protein retention in ER lumen (GO:0006621) | 2.48246078 |
| 171 | positive regulation of steroid hormone secretion (GO:2000833) | 2.48130762 |
| 172 | developmental pigmentation (GO:0048066) | 2.47916497 |
| 173 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.46672883 |
| 174 | blood coagulation, intrinsic pathway (GO:0007597) | 2.46448348 |
| 175 | regulation of hormone metabolic process (GO:0032350) | 2.45655905 |
| 176 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.45555952 |
| 177 | insulin secretion (GO:0030073) | 2.44619152 |
| 178 | inner ear receptor cell differentiation (GO:0060113) | 2.44572896 |
| 179 | cellular response to cholesterol (GO:0071397) | 2.43967338 |
| 180 | positive regulation of synapse maturation (GO:0090129) | 2.42365020 |
| 181 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.41749422 |
| 182 | neurotransmitter transport (GO:0006836) | 2.41432999 |
| 183 | paraxial mesoderm development (GO:0048339) | 2.41091182 |
| 184 | positive regulation of dendrite development (GO:1900006) | 2.38307711 |
| 185 | synaptic vesicle endocytosis (GO:0048488) | 2.38028830 |
| 186 | neuron projection regeneration (GO:0031102) | 2.36682334 |
| 187 | regulation of synaptic plasticity (GO:0048167) | 2.35576414 |
| 188 | * membrane assembly (GO:0071709) | 2.35078680 |
| 189 | glutamate receptor signaling pathway (GO:0007215) | 2.34970806 |
| 190 | transmission of nerve impulse (GO:0019226) | 2.33674310 |
| 191 | dendritic spine morphogenesis (GO:0060997) | 2.32392783 |
| 192 | regulation of respiratory gaseous exchange (GO:0043576) | 2.32209642 |
| 193 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.32169510 |
| 194 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.31697840 |
| 195 | * dendrite morphogenesis (GO:0048813) | 2.31641945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.84665744 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.13383556 |
| 3 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.61286046 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.50033418 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.29212936 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.17003793 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16387460 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14588474 |
| 9 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.06556367 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.05876710 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.05306821 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03353102 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.01324622 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.00849176 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00533154 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.99638471 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.98527851 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97962427 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.97255126 |
| 20 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.92085914 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.90162448 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88893162 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.88178292 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85055823 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.84759936 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83629301 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80887258 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.79239771 |
| 29 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.78021211 |
| 30 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.75447587 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.73380217 |
| 32 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71274992 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.68881833 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.67177897 |
| 35 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.65894839 |
| 36 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.63829443 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62824875 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62612018 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.61587663 |
| 40 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.61317037 |
| 41 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60576564 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58895930 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.58877497 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58585567 |
| 45 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57766046 |
| 46 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.57391967 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57173611 |
| 48 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55669949 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.55330701 |
| 50 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.55288602 |
| 51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.54957718 |
| 52 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.54218880 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.54117006 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.54117006 |
| 55 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.52960808 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51413442 |
| 57 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.51308545 |
| 58 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.50421047 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.49781561 |
| 60 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.48755030 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.47943101 |
| 62 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.47723154 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.47167817 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.45893298 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45124861 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45086437 |
| 67 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.45045934 |
| 68 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.43393746 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42665042 |
| 70 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.42111188 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42049209 |
| 72 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.39642058 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38750901 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37579623 |
| 75 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.36548565 |
| 76 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.35411300 |
| 77 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.34938949 |
| 78 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.34803526 |
| 79 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.34506240 |
| 80 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.34099224 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33842760 |
| 82 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.32909282 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31753897 |
| 84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.31362009 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30565283 |
| 86 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.28902673 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.24943915 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24278336 |
| 89 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.24189159 |
| 90 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.23642323 |
| 91 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23079171 |
| 92 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.23020850 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22017165 |
| 94 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21873626 |
| 95 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20544933 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20215827 |
| 97 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.19841623 |
| 98 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.19238087 |
| 99 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19129325 |
| 100 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.18995947 |
| 101 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.18853465 |
| 102 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.18789171 |
| 103 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18335969 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18023259 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17869725 |
| 106 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17685610 |
| 107 | AR_19668381_ChIP-Seq_PC3_Human | 1.16820390 |
| 108 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16584547 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15747286 |
| 110 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.14698249 |
| 111 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.13009419 |
| 112 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12279654 |
| 113 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.12099485 |
| 114 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12012404 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11985312 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11575256 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.11570396 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11249269 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10902979 |
| 120 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09981790 |
| 121 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.08388971 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07571925 |
| 123 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07482101 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07247018 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07065598 |
| 126 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06987948 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06504803 |
| 128 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06377449 |
| 129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05781332 |
| 130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05253843 |
| 131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05161188 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04595012 |
| 133 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04309679 |
| 134 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.02631058 |
| 135 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.01859131 |
| 136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.01689936 |
| 137 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01304936 |
| 138 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01284223 |
| 139 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.01198591 |
| 140 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01167677 |
| 141 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.01002234 |
| 142 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00414869 |
| 143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00189149 |
| 144 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00140984 |
| 145 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.99733353 |
| 146 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.98666135 |
| 147 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97913073 |
| 148 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97714442 |
| 149 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97473326 |
| 150 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94513338 |
| 151 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94432991 |
| 152 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.94332301 |
| 153 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.93971694 |
| 154 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93633898 |
| 155 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92859453 |
| 156 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.92607547 |
| 157 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.92316768 |
| 158 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91669651 |
| 159 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91666311 |
| 160 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90610675 |
| 161 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.89873579 |
| 162 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89368873 |
| 163 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88240461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.38700050 |
| 2 | MP0003136_yellow_coat_color | 4.35260936 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.80269176 |
| 4 | MP0004270_analgesia | 3.73567727 |
| 5 | MP0005409_darkened_coat_color | 3.73203390 |
| 6 | MP0001188_hyperpigmentation | 3.60714059 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.46642462 |
| 8 | MP0004043_abnormal_pH_regulation | 3.43800793 |
| 9 | MP0003880_abnormal_central_pattern | 3.15190974 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.98899075 |
| 11 | MP0006072_abnormal_retinal_apoptosis | 2.96632501 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.96130290 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.78406257 |
| 14 | MP0002638_abnormal_pupillary_reflex | 2.76149949 |
| 15 | MP0004381_abnormal_hair_follicle | 2.75237998 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.58708459 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.52583494 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.51662671 |
| 19 | MP0002693_abnormal_pancreas_physiology | 2.48789583 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 2.46753324 |
| 21 | MP0001944_abnormal_pancreas_morphology | 2.39867252 |
| 22 | MP0001486_abnormal_startle_reflex | 2.33145902 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.27656845 |
| 24 | MP0002064_seizures | 2.24865965 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.24538474 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.20237063 |
| 27 | MP0003868_abnormal_feces_composition | 2.17060585 |
| 28 | MP0000566_synostosis | 2.16533507 |
| 29 | MP0005174_abnormal_tail_pigmentation | 2.16129146 |
| 30 | MP0000778_abnormal_nervous_system | 2.14584570 |
| 31 | MP0000678_abnormal_parathyroid_gland | 2.14361146 |
| 32 | MP0003690_abnormal_glial_cell | 2.06747574 |
| 33 | MP0002063_abnormal_learning/memory/cond | 2.06600265 |
| 34 | MP0005257_abnormal_intraocular_pressure | 2.01769490 |
| 35 | MP0001984_abnormal_olfaction | 2.00654414 |
| 36 | MP0000015_abnormal_ear_pigmentation | 2.00056099 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.99810110 |
| 38 | MP0001346_abnormal_lacrimal_gland | 1.90534194 |
| 39 | MP0002272_abnormal_nervous_system | 1.83728492 |
| 40 | MP0008569_lethality_at_weaning | 1.82301150 |
| 41 | MP0005220_abnormal_exocrine_pancreas | 1.80091020 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.79137609 |
| 43 | MP0005253_abnormal_eye_physiology | 1.79100396 |
| 44 | MP0003329_amyloid_beta_deposits | 1.78455104 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.76085707 |
| 46 | MP0009745_abnormal_behavioral_response | 1.75322316 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.70922651 |
| 48 | MP0002177_abnormal_outer_ear | 1.66870094 |
| 49 | MP0002736_abnormal_nociception_after | 1.65868905 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.65438077 |
| 51 | MP0000613_abnormal_salivary_gland | 1.61479785 |
| 52 | MP0003724_increased_susceptibility_to | 1.60466065 |
| 53 | MP0000920_abnormal_myelination | 1.59198860 |
| 54 | MP0003634_abnormal_glial_cell | 1.56842983 |
| 55 | MP0000955_abnormal_spinal_cord | 1.55698778 |
| 56 | MP0002822_catalepsy | 1.55614502 |
| 57 | MP0003283_abnormal_digestive_organ | 1.55124141 |
| 58 | MP0000049_abnormal_middle_ear | 1.48658717 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.48191295 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.45865276 |
| 61 | MP0000681_abnormal_thyroid_gland | 1.44261340 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.43731371 |
| 63 | MP0000631_abnormal_neuroendocrine_gland | 1.43102970 |
| 64 | MP0003011_delayed_dark_adaptation | 1.41684862 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.41142670 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.41124058 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.41106876 |
| 68 | MP0005171_absent_coat_pigmentation | 1.37975384 |
| 69 | MP0004858_abnormal_nervous_system | 1.35025446 |
| 70 | MP0003632_abnormal_nervous_system | 1.34492448 |
| 71 | MP0002938_white_spotting | 1.33487444 |
| 72 | MP0002095_abnormal_skin_pigmentation | 1.31465143 |
| 73 | MP0009046_muscle_twitch | 1.29303758 |
| 74 | * MP0001177_atelectasis | 1.28310421 |
| 75 | MP0008789_abnormal_olfactory_epithelium | 1.27336133 |
| 76 | MP0001970_abnormal_pain_threshold | 1.25653281 |
| 77 | * MP0000579_abnormal_nail_morphology | 1.25083992 |
| 78 | MP0002152_abnormal_brain_morphology | 1.24983840 |
| 79 | * MP0002882_abnormal_neuron_morphology | 1.24320050 |
| 80 | MP0002067_abnormal_sensory_capabilities | 1.20258298 |
| 81 | MP0000372_irregular_coat_pigmentation | 1.19458819 |
| 82 | MP0000013_abnormal_adipose_tissue | 1.19139040 |
| 83 | MP0002733_abnormal_thermal_nociception | 1.18031261 |
| 84 | MP0004811_abnormal_neuron_physiology | 1.18025514 |
| 85 | MP0003633_abnormal_nervous_system | 1.15780017 |
| 86 | * MP0002557_abnormal_social/conspecific_i | 1.14632091 |
| 87 | MP0001270_distended_abdomen | 1.13360479 |
| 88 | MP0000751_myopathy | 1.13318467 |
| 89 | MP0010368_abnormal_lymphatic_system | 1.12551706 |
| 90 | MP0000537_abnormal_urethra_morphology | 1.12130027 |
| 91 | MP0003941_abnormal_skin_development | 1.10565882 |
| 92 | MP0003195_calcinosis | 1.09977506 |
| 93 | MP0003861_abnormal_nervous_system | 1.09342937 |
| 94 | MP0001919_abnormal_reproductive_system | 1.08858376 |
| 95 | MP0003631_nervous_system_phenotype | 1.08488480 |
| 96 | MP0010030_abnormal_orbit_morphology | 1.08473652 |
| 97 | MP0003879_abnormal_hair_cell | 1.08355156 |
| 98 | MP0000428_abnormal_craniofacial_morphol | 1.08315245 |
| 99 | MP0002254_reproductive_system_inflammat | 1.08295517 |
| 100 | MP0002009_preneoplasia | 1.05210191 |
| 101 | MP0000762_abnormal_tongue_morphology | 1.04630612 |
| 102 | * MP0002066_abnormal_motor_capabilities/c | 1.03619036 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 1.03138888 |
| 104 | MP0002184_abnormal_innervation | 1.02303186 |
| 105 | MP0003119_abnormal_digestive_system | 0.99451312 |
| 106 | MP0002751_abnormal_autonomic_nervous | 0.96518471 |
| 107 | MP0000534_abnormal_ureter_morphology | 0.96244898 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.96037888 |
| 109 | MP0002089_abnormal_postnatal_growth/wei | 0.95452809 |
| 110 | MP0003122_maternal_imprinting | 0.95434538 |
| 111 | MP0003123_paternal_imprinting | 0.95259286 |
| 112 | MP0002653_abnormal_ependyma_morphology | 0.94101919 |
| 113 | MP0002697_abnormal_eye_size | 0.92091245 |
| 114 | MP0000026_abnormal_inner_ear | 0.91614721 |
| 115 | MP0003385_abnormal_body_wall | 0.91389798 |
| 116 | MP0000462_abnormal_digestive_system | 0.91240440 |
| 117 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91139454 |
| 118 | MP0003938_abnormal_ear_development | 0.90978592 |
| 119 | MP0005408_hypopigmentation | 0.89820451 |
| 120 | MP0002163_abnormal_gland_morphology | 0.89155763 |
| 121 | MP0002233_abnormal_nose_morphology | 0.87718448 |
| 122 | MP0002249_abnormal_larynx_morphology | 0.86232431 |
| 123 | MP0005499_abnormal_olfactory_system | 0.85687269 |
| 124 | MP0005394_taste/olfaction_phenotype | 0.85687269 |
| 125 | MP0000749_muscle_degeneration | 0.85112448 |
| 126 | MP0001186_pigmentation_phenotype | 0.84251017 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.83821853 |
| 128 | MP0004272_abnormal_basement_membrane | 0.83682969 |
| 129 | MP0003252_abnormal_bile_duct | 0.83497471 |
| 130 | MP0000747_muscle_weakness | 0.82206681 |
| 131 | MP0001661_extended_life_span | 0.81777226 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.81406062 |
| 133 | MP0002928_abnormal_bile_duct | 0.79756368 |
| 134 | MP0005391_vision/eye_phenotype | 0.79200591 |
| 135 | MP0001440_abnormal_grooming_behavior | 0.78534198 |
| 136 | MP0009053_abnormal_anal_canal | 0.78381922 |
| 137 | MP0004924_abnormal_behavior | 0.77624666 |
| 138 | MP0005386_behavior/neurological_phenoty | 0.77624666 |
| 139 | MP0002138_abnormal_hepatobiliary_system | 0.76970549 |
| 140 | MP0003115_abnormal_respiratory_system | 0.76052424 |
| 141 | MP0005058_abnormal_lysosome_morphology | 0.74792633 |
| 142 | MP0000383_abnormal_hair_follicle | 0.74710877 |
| 143 | MP0001324_abnormal_eye_pigmentation | 0.73976640 |
| 144 | MP0001963_abnormal_hearing_physiology | 0.73868311 |
| 145 | MP0003942_abnormal_urinary_system | 0.73651403 |
| 146 | MP0004782_abnormal_surfactant_physiolog | 0.73492198 |
| 147 | * MP0002752_abnormal_somatic_nervous | 0.73483783 |
| 148 | MP0001849_ear_inflammation | 0.73235308 |
| 149 | MP0002116_abnormal_craniofacial_bone | 0.72300516 |
| 150 | MP0001485_abnormal_pinna_reflex | 0.70850197 |
| 151 | MP0005195_abnormal_posterior_eye | 0.70577762 |
| 152 | MP0004885_abnormal_endolymph | 0.70562347 |
| 153 | MP0001299_abnormal_eye_distance/ | 0.70312856 |
| 154 | MP0000538_abnormal_urinary_bladder | 0.70138866 |
| 155 | MP0005645_abnormal_hypothalamus_physiol | 0.69975981 |
| 156 | * MP0003937_abnormal_limbs/digits/tail_de | 0.69392491 |
| 157 | MP0005167_abnormal_blood-brain_barrier | 0.69128774 |
| 158 | MP0005084_abnormal_gallbladder_morpholo | 0.68057865 |
| 159 | MP0002896_abnormal_bone_mineralization | 0.66714340 |
| 160 | MP0000467_abnormal_esophagus_morphology | 0.65829127 |
| 161 | MP0009250_abnormal_appendicular_skeleto | 0.63988217 |
| 162 | MP0003953_abnormal_hormone_level | 0.63921263 |
| 163 | MP0001664_abnormal_digestion | 0.63042992 |
| 164 | MP0002229_neurodegeneration | 0.62216456 |
| 165 | MP0001765_abnormal_ion_homeostasis | 0.59839691 |
| 166 | MP0002909_abnormal_adrenal_gland | 0.57634854 |
| 167 | MP0005389_reproductive_system_phenotype | 0.56897500 |
| 168 | MP0009384_cardiac_valve_regurgitation | 0.56095790 |
| 169 | MP0002075_abnormal_coat/hair_pigmentati | 0.55796984 |
| 170 | * MP0002098_abnormal_vibrissa_morphology | 0.54958355 |
| 171 | MP0005085_abnormal_gallbladder_physiolo | 0.54955536 |
| 172 | MP0002998_abnormal_bone_remodeling | 0.54729939 |
| 173 | MP0009643_abnormal_urine_homeostasis | 0.52171359 |
| 174 | MP0008995_early_reproductive_senescence | 0.50250875 |
| 175 | MP0005636_abnormal_mineral_homeostasis | 0.49613752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I transferrin isoform profile (HP:0003642) | 5.79486956 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 5.56244714 |
| 3 | Reduced antithrombin III activity (HP:0001976) | 5.40339982 |
| 4 | Hypothermia (HP:0002045) | 5.13434435 |
| 5 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.08054545 |
| 6 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.64081906 |
| 7 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.64081906 |
| 8 | Abnormal protein glycosylation (HP:0012346) | 4.64081906 |
| 9 | Abnormal glycosylation (HP:0012345) | 4.64081906 |
| 10 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.20926875 |
| 11 | Myokymia (HP:0002411) | 3.80755128 |
| 12 | Symptomatic seizures (HP:0011145) | 3.71664530 |
| 13 | Hypoglycemic seizures (HP:0002173) | 3.65775355 |
| 14 | Focal motor seizures (HP:0011153) | 3.62103495 |
| 15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.56458249 |
| 16 | Attenuation of retinal blood vessels (HP:0007843) | 3.43065696 |
| 17 | Action tremor (HP:0002345) | 3.41188157 |
| 18 | Aplasia involving bones of the extremities (HP:0009825) | 3.37587690 |
| 19 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.37587690 |
| 20 | Aplasia of the phalanges of the hand (HP:0009802) | 3.37587690 |
| 21 | Megalencephaly (HP:0001355) | 3.32856181 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.31746641 |
| 23 | Late onset (HP:0003584) | 3.30150796 |
| 24 | Decreased circulating renin level (HP:0003351) | 3.24366915 |
| 25 | Congenital sensorineural hearing impairment (HP:0008527) | 3.21154637 |
| 26 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.16940891 |
| 27 | Focal seizures (HP:0007359) | 3.12654119 |
| 28 | Cortical visual impairment (HP:0100704) | 3.12475115 |
| 29 | True hermaphroditism (HP:0010459) | 3.11898528 |
| 30 | Thyroid-stimulating hormone excess (HP:0002925) | 3.10237449 |
| 31 | Abnormal sex determination (HP:0012244) | 3.06556022 |
| 32 | Sex reversal (HP:0012245) | 3.06556022 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.04532122 |
| 34 | Abnormality of binocular vision (HP:0011514) | 3.03974806 |
| 35 | Diplopia (HP:0000651) | 3.03974806 |
| 36 | Osteomalacia (HP:0002749) | 3.01579645 |
| 37 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.97509671 |
| 38 | Hypoplasia of the fovea (HP:0007750) | 2.97509671 |
| 39 | Decreased central vision (HP:0007663) | 2.96860824 |
| 40 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.90570830 |
| 41 | Tubulointerstitial nephritis (HP:0001970) | 2.78973654 |
| 42 | Neonatal short-limb short stature (HP:0008921) | 2.75907274 |
| 43 | Joint hemorrhage (HP:0005261) | 2.75455092 |
| 44 | Bronchomalacia (HP:0002780) | 2.74630151 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72684742 |
| 46 | Abnormality of the fovea (HP:0000493) | 2.71883866 |
| 47 | Abnormality of secondary sexual hair (HP:0009888) | 2.69679258 |
| 48 | Abnormality of the axillary hair (HP:0100134) | 2.69679258 |
| 49 | Ankle clonus (HP:0011448) | 2.61480345 |
| 50 | Hemiplegia (HP:0002301) | 2.59227214 |
| 51 | Hemiparesis (HP:0001269) | 2.56199635 |
| 52 | Atonic seizures (HP:0010819) | 2.54222746 |
| 53 | Severe visual impairment (HP:0001141) | 2.53528892 |
| 54 | Hyperactive renin-angiotensin system (HP:0000841) | 2.53338557 |
| 55 | Turricephaly (HP:0000262) | 2.52698613 |
| 56 | Increased circulating renin level (HP:0000848) | 2.48650135 |
| 57 | Coronal craniosynostosis (HP:0004440) | 2.47744028 |
| 58 | Pancreatic cysts (HP:0001737) | 2.46457343 |
| 59 | Partial duplication of thumb phalanx (HP:0009944) | 2.45974637 |
| 60 | Pancreatic fibrosis (HP:0100732) | 2.45830962 |
| 61 | Shallow orbits (HP:0000586) | 2.45807049 |
| 62 | Alacrima (HP:0000522) | 2.43047672 |
| 63 | Peripheral hypomyelination (HP:0007182) | 2.42786610 |
| 64 | Optic nerve hypoplasia (HP:0000609) | 2.42560535 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.39577925 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.34826289 |
| 67 | Hyperkalemia (HP:0002153) | 2.34213312 |
| 68 | Popliteal pterygium (HP:0009756) | 2.32038941 |
| 69 | Generalized tonic-clonic seizures (HP:0002069) | 2.30863838 |
| 70 | Cerebral inclusion bodies (HP:0100314) | 2.30339335 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 2.28660438 |
| 72 | Dysdiadochokinesis (HP:0002075) | 2.26825028 |
| 73 | Abnormality of magnesium homeostasis (HP:0004921) | 2.24038004 |
| 74 | Renal cortical cysts (HP:0000803) | 2.23966739 |
| 75 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.22812059 |
| 76 | Morphological abnormality of the inner ear (HP:0011390) | 2.22653239 |
| 77 | Choanal stenosis (HP:0000452) | 2.20904503 |
| 78 | Bradycardia (HP:0001662) | 2.19895848 |
| 79 | Abolished electroretinogram (ERG) (HP:0000550) | 2.17179342 |
| 80 | Overriding aorta (HP:0002623) | 2.14039593 |
| 81 | Insomnia (HP:0100785) | 2.13936511 |
| 82 | Lip pit (HP:0100267) | 2.11836192 |
| 83 | Increased corneal curvature (HP:0100692) | 2.10937846 |
| 84 | Keratoconus (HP:0000563) | 2.10937846 |
| 85 | Cystic liver disease (HP:0006706) | 2.10361583 |
| 86 | Abnormality of cochlea (HP:0000375) | 2.07693203 |
| 87 | Abnormality of the diencephalon (HP:0010662) | 2.06244967 |
| 88 | Vertebral arch anomaly (HP:0008438) | 2.05477786 |
| 89 | Partial duplication of the phalanx of hand (HP:0009999) | 2.04557060 |
| 90 | Supranuclear gaze palsy (HP:0000605) | 2.04219808 |
| 91 | Nonprogressive disorder (HP:0003680) | 2.04077388 |
| 92 | Abnormality of the ischium (HP:0003174) | 2.02995534 |
| 93 | Intestinal atresia (HP:0011100) | 2.02382633 |
| 94 | Obstructive sleep apnea (HP:0002870) | 2.02204765 |
| 95 | Cerebral palsy (HP:0100021) | 1.98190019 |
| 96 | Tracheomalacia (HP:0002779) | 1.97267316 |
| 97 | Febrile seizures (HP:0002373) | 1.96451655 |
| 98 | Truncal ataxia (HP:0002078) | 1.96273035 |
| 99 | Abnormal pancreas size (HP:0012094) | 1.95585195 |
| 100 | Progressive neurologic deterioration (HP:0002344) | 1.95224050 |
| 101 | Menorrhagia (HP:0000132) | 1.95200711 |
| 102 | Abnormality of renal resorption (HP:0011038) | 1.93833300 |
| 103 | Median cleft lip (HP:0000161) | 1.93391636 |
| 104 | Epileptic encephalopathy (HP:0200134) | 1.93347997 |
| 105 | Abnormality of renin-angiotensin system (HP:0000847) | 1.93344731 |
| 106 | Patchy hypopigmentation of hair (HP:0011365) | 1.91807412 |
| 107 | Hyperacusis (HP:0010780) | 1.91493467 |
| 108 | Abnormal eating behavior (HP:0100738) | 1.91490637 |
| 109 | Renal Fanconi syndrome (HP:0001994) | 1.90736686 |
| 110 | Male pseudohermaphroditism (HP:0000037) | 1.90726694 |
| 111 | Hepatic necrosis (HP:0002605) | 1.90680450 |
| 112 | Mucopolysacchariduria (HP:0008155) | 1.90249557 |
| 113 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90249557 |
| 114 | Abnormality of the intrinsic pathway (HP:0010989) | 1.89574292 |
| 115 | Abnormality of urine glucose concentration (HP:0011016) | 1.89099784 |
| 116 | Glycosuria (HP:0003076) | 1.89099784 |
| 117 | Abnormality of dental color (HP:0011073) | 1.89047571 |
| 118 | Scanning speech (HP:0002168) | 1.88157046 |
| 119 | Hypoplasia of the uterus (HP:0000013) | 1.87894921 |
| 120 | Intention tremor (HP:0002080) | 1.87246465 |
| 121 | Dysmetria (HP:0001310) | 1.86197244 |
| 122 | Spastic gait (HP:0002064) | 1.85962007 |
| 123 | * Cutaneous syndactyly (HP:0012725) | 1.84128301 |
| 124 | * Split foot (HP:0001839) | 1.83808649 |
| 125 | Thin ribs (HP:0000883) | 1.83024149 |
| 126 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82148730 |
| 127 | Hypokalemia (HP:0002900) | 1.82140282 |
| 128 | Decreased lacrimation (HP:0000633) | 1.80860729 |
| 129 | Thickened helices (HP:0000391) | 1.79985316 |
| 130 | Optic disc pallor (HP:0000543) | 1.79645105 |
| 131 | Renovascular hypertension (HP:0100817) | 1.79272251 |
| 132 | Abdominal distention (HP:0003270) | 1.79146442 |
| 133 | Morphological abnormality of the middle ear (HP:0008609) | 1.79096241 |
| 134 | * Cutaneous finger syndactyly (HP:0010554) | 1.78964250 |
| 135 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.78958846 |
| 136 | Hammertoe (HP:0001765) | 1.78742723 |
| 137 | Renal tubular dysfunction (HP:0000124) | 1.77342339 |
| 138 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.76958384 |
| 139 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.76199714 |
| 140 | Overgrowth (HP:0001548) | 1.75264454 |
| 141 | Akinesia (HP:0002304) | 1.74860186 |
| 142 | Ulnar bowing (HP:0003031) | 1.74761336 |
| 143 | Acne (HP:0001061) | 1.74751951 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74605384 |
| 145 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74605384 |
| 146 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74605384 |
| 147 | Hyporeflexia of lower limbs (HP:0002600) | 1.74179989 |
| 148 | Testicular atrophy (HP:0000029) | 1.74149572 |
| 149 | Papilledema (HP:0001085) | 1.74027050 |
| 150 | Hyperglycemia (HP:0003074) | 1.73583679 |
| 151 | Abnormality of potassium homeostasis (HP:0011042) | 1.73340441 |
| 152 | Flat capital femoral epiphysis (HP:0003370) | 1.72664837 |
| 153 | Bifid tongue (HP:0010297) | 1.72663348 |
| 154 | Flared iliac wings (HP:0002869) | 1.72646118 |
| 155 | Arnold-Chiari malformation (HP:0002308) | 1.71609191 |
| 156 | Anencephaly (HP:0002323) | 1.71163321 |
| 157 | Elfin facies (HP:0004428) | 1.70633941 |
| 158 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.69578297 |
| 159 | Abnormality of the 4th metacarpal (HP:0010012) | 1.69530882 |
| 160 | Hyperphosphaturia (HP:0003109) | 1.69425308 |
| 161 | Congenital hepatic fibrosis (HP:0002612) | 1.69257209 |
| 162 | Broad metatarsal (HP:0001783) | 1.69128092 |
| 163 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.68810214 |
| 164 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.68810214 |
| 165 | Abnormality of glycolipid metabolism (HP:0010969) | 1.68810214 |
| 166 | Absent eyebrow (HP:0002223) | 1.68562751 |
| 167 | Sleep apnea (HP:0010535) | 1.67280732 |
| 168 | Omphalocele (HP:0001539) | 1.66339890 |
| 169 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.65470300 |
| 170 | Hypoplasia of the iris (HP:0007676) | 1.64957472 |
| 171 | Preaxial foot polydactyly (HP:0001841) | 1.63719141 |
| 172 | Bowel incontinence (HP:0002607) | 1.63624408 |
| 173 | Wide anterior fontanel (HP:0000260) | 1.63257232 |
| 174 | Neoplasm of the heart (HP:0100544) | 1.62838226 |
| 175 | Limited hip movement (HP:0008800) | 1.62440096 |
| 176 | Tetraplegia (HP:0002445) | 1.61973121 |
| 177 | Ankyloglossia (HP:0010296) | 1.60208860 |
| 178 | Mixed hearing impairment (HP:0000410) | 1.59563455 |
| 179 | Urethral obstruction (HP:0000796) | 1.58131438 |
| 180 | Postural instability (HP:0002172) | 1.58120020 |
| 181 | Mild short stature (HP:0003502) | 1.57732007 |
| 182 | Bundle branch block (HP:0011710) | 1.56146246 |
| 183 | Increased nuchal translucency (HP:0010880) | 1.55988465 |
| 184 | Hepatoblastoma (HP:0002884) | 1.55928169 |
| 185 | Trigonocephaly (HP:0000243) | 1.54907331 |
| 186 | Bowel diverticulosis (HP:0005222) | 1.54330357 |
| 187 | Vitreoretinal degeneration (HP:0000655) | 1.53059634 |
| 188 | Dialeptic seizures (HP:0011146) | 1.51647881 |
| 189 | Urinary urgency (HP:0000012) | 1.51481923 |
| 190 | Absence seizures (HP:0002121) | 1.51432905 |
| 191 | Duplication of thumb phalanx (HP:0009942) | 1.50260136 |
| 192 | Difficulty running (HP:0009046) | 1.49806086 |
| 193 | Abnormality of the lower motor neuron (HP:0002366) | 1.48998719 |
| 194 | Pheochromocytoma (HP:0002666) | 1.47391003 |
| 195 | Myotonia (HP:0002486) | 1.45252912 |
| 196 | Renal duplication (HP:0000075) | 1.44901802 |
| 197 | Bladder diverticulum (HP:0000015) | 1.44672844 |
| 198 | Vertebral clefting (HP:0008428) | 1.43544955 |
| 199 | Lower limb muscle weakness (HP:0007340) | 1.43421229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 6.03147802 |
| 2 | CASK | 5.06377085 |
| 3 | MKNK2 | 4.37080869 |
| 4 | INSRR | 4.08153664 |
| 5 | MARK1 | 3.75977494 |
| 6 | EPHA4 | 3.75384607 |
| 7 | NTRK2 | 3.44928389 |
| 8 | EIF2AK3 | 3.44535549 |
| 9 | IRAK3 | 2.77632262 |
| 10 | NLK | 2.65629914 |
| 11 | IRAK2 | 2.46708073 |
| 12 | MAPK15 | 2.42234633 |
| 13 | PAK6 | 2.40849198 |
| 14 | TYRO3 | 2.40304278 |
| 15 | MUSK | 2.28688381 |
| 16 | RIPK1 | 2.22696921 |
| 17 | MKNK1 | 2.09901581 |
| 18 | FGFR2 | 1.97406454 |
| 19 | IRAK4 | 1.95120194 |
| 20 | HIPK2 | 1.90146759 |
| 21 | IRAK1 | 1.90092630 |
| 22 | PDGFRA | 1.87446769 |
| 23 | PASK | 1.87261766 |
| 24 | LATS2 | 1.87233404 |
| 25 | CAMKK2 | 1.81542764 |
| 26 | PRPF4B | 1.74309088 |
| 27 | STK16 | 1.54320363 |
| 28 | PNCK | 1.42954231 |
| 29 | TLK1 | 1.33503759 |
| 30 | FES | 1.31448572 |
| 31 | PRKD2 | 1.27869931 |
| 32 | EIF2AK2 | 1.26479274 |
| 33 | PKN1 | 1.25816827 |
| 34 | BMPR2 | 1.24315290 |
| 35 | SRPK1 | 1.24280699 |
| 36 | PBK | 1.23172046 |
| 37 | MAP3K9 | 1.22969770 |
| 38 | MINK1 | 1.20927162 |
| 39 | LATS1 | 1.20566726 |
| 40 | DAPK2 | 1.17980635 |
| 41 | PLK2 | 1.17719515 |
| 42 | LMTK2 | 1.16968548 |
| 43 | STK38L | 1.13054489 |
| 44 | KSR2 | 1.12429151 |
| 45 | CAMKK1 | 1.10945890 |
| 46 | ZAK | 1.10758435 |
| 47 | FLT3 | 1.09790866 |
| 48 | CDK5 | 1.06679534 |
| 49 | ROCK2 | 1.04499012 |
| 50 | ICK | 1.03785024 |
| 51 | TEC | 1.02918294 |
| 52 | YES1 | 1.02713598 |
| 53 | TAOK3 | 1.01577610 |
| 54 | NME2 | 1.00925873 |
| 55 | NTRK3 | 0.99592703 |
| 56 | MAP2K2 | 0.98176656 |
| 57 | MST1R | 0.96788184 |
| 58 | PRKD3 | 0.92521720 |
| 59 | PHKG1 | 0.91746863 |
| 60 | PHKG2 | 0.91746863 |
| 61 | CAMK1G | 0.91285611 |
| 62 | BMX | 0.91190501 |
| 63 | WNK4 | 0.90893955 |
| 64 | CDK3 | 0.90397156 |
| 65 | PINK1 | 0.89674321 |
| 66 | EPHB2 | 0.89341560 |
| 67 | DYRK1A | 0.88432161 |
| 68 | FER | 0.88326890 |
| 69 | NME1 | 0.88191478 |
| 70 | MAPK10 | 0.85275034 |
| 71 | MARK2 | 0.85227866 |
| 72 | SGK3 | 0.85190301 |
| 73 | EEF2K | 0.84659308 |
| 74 | FGFR1 | 0.82795128 |
| 75 | ERBB2 | 0.80238301 |
| 76 | PIK3CG | 0.79795799 |
| 77 | BMPR1B | 0.79418568 |
| 78 | ERBB4 | 0.78756629 |
| 79 | PDGFRB | 0.76690863 |
| 80 | SGK1 | 0.76628024 |
| 81 | BCKDK | 0.76339146 |
| 82 | CDK15 | 0.75600930 |
| 83 | PRKCG | 0.75004111 |
| 84 | RET | 0.74901811 |
| 85 | GRK1 | 0.71640220 |
| 86 | CDK18 | 0.71033248 |
| 87 | ROCK1 | 0.70236743 |
| 88 | CDK12 | 0.69865004 |
| 89 | EPHA3 | 0.69214791 |
| 90 | VRK1 | 0.68818597 |
| 91 | NEK6 | 0.68344322 |
| 92 | STK39 | 0.67920628 |
| 93 | CDK11A | 0.67635759 |
| 94 | ADRBK2 | 0.66792414 |
| 95 | DMPK | 0.66304669 |
| 96 | CAMK1 | 0.66085897 |
| 97 | FGFR4 | 0.65477697 |
| 98 | MAP3K4 | 0.65406423 |
| 99 | PRKCE | 0.64910051 |
| 100 | STK38 | 0.63053820 |
| 101 | BRAF | 0.63046131 |
| 102 | PTK2 | 0.62342257 |
| 103 | DDR2 | 0.61729983 |
| 104 | WNK1 | 0.60886304 |
| 105 | CDK14 | 0.60417130 |
| 106 | MAP3K10 | 0.60111307 |
| 107 | MAP2K7 | 0.60043990 |
| 108 | CAMK2B | 0.59585858 |
| 109 | PRKAA2 | 0.59491279 |
| 110 | CDC42BPA | 0.58383313 |
| 111 | PRKCH | 0.57307389 |
| 112 | ALK | 0.57023039 |
| 113 | CSNK1G2 | 0.53803772 |
| 114 | MTOR | 0.53535145 |
| 115 | MAPK13 | 0.52947218 |
| 116 | MAP3K14 | 0.52752425 |
| 117 | RPS6KA3 | 0.52401105 |
| 118 | ERN1 | 0.52295886 |
| 119 | MOS | 0.51503585 |
| 120 | KSR1 | 0.51408313 |
| 121 | CAMK2D | 0.50563735 |
| 122 | MAP3K1 | 0.50181515 |
| 123 | MAPK12 | 0.49886139 |
| 124 | MAP3K7 | 0.49725181 |
| 125 | ARAF | 0.49485083 |
| 126 | BRSK1 | 0.49245106 |
| 127 | MAP3K2 | 0.48557180 |
| 128 | ERBB3 | 0.47530574 |
| 129 | RPS6KB1 | 0.45635313 |
| 130 | PRKDC | 0.44035715 |
| 131 | CAMK1D | 0.43763615 |
| 132 | FRK | 0.43242817 |
| 133 | DYRK1B | 0.43117887 |
| 134 | PAK2 | 0.42883961 |
| 135 | BRD4 | 0.42871703 |
| 136 | CDK8 | 0.41968801 |
| 137 | PIK3CA | 0.41831536 |
| 138 | FGFR3 | 0.41726808 |
| 139 | TIE1 | 0.41168385 |
| 140 | TRIB3 | 0.41059398 |
| 141 | CLK1 | 0.40330859 |
| 142 | MET | 0.40196965 |
| 143 | NTRK1 | 0.40193689 |
| 144 | PRKG2 | 0.40158714 |
| 145 | STK11 | 0.40076644 |
| 146 | CSNK1D | 0.39796904 |
| 147 | UHMK1 | 0.39619370 |
| 148 | AKT3 | 0.39222913 |
| 149 | DYRK3 | 0.38057472 |
| 150 | CSK | 0.35466143 |
| 151 | PRKG1 | 0.35291233 |
| 152 | SIK1 | 0.33832241 |
| 153 | PRKACA | 0.33757947 |
| 154 | PIM2 | 0.33533368 |
| 155 | CAMK2G | 0.33137629 |
| 156 | NUAK1 | 0.32623852 |
| 157 | IKBKE | 0.32393959 |
| 158 | GRK7 | 0.31133709 |
| 159 | PRKCI | 0.29687367 |
| 160 | CAMK2A | 0.29262406 |
| 161 | GSK3A | 0.28936577 |
| 162 | SGK2 | 0.28229052 |
| 163 | SGK494 | 0.27778118 |
| 164 | SGK223 | 0.27778118 |
| 165 | CAMK4 | 0.27738731 |
| 166 | PRKD1 | 0.27224024 |
| 167 | OBSCN | 0.23980974 |
| 168 | BTK | 0.23818626 |
| 169 | CSNK1A1L | 0.22854734 |
| 170 | ADRBK1 | 0.22509452 |
| 171 | CDK9 | 0.21924469 |
| 172 | CSNK1A1 | 0.21405217 |
| 173 | KIT | 0.21078088 |
| 174 | IGF1R | 0.20426931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.90572735 |
| 2 | Protein export_Homo sapiens_hsa03060 | 6.78829045 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.53819172 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.01858995 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.73870610 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.55944012 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.41252141 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.08024501 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07255911 |
| 10 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.04140750 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 1.98840969 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.98374621 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.97346241 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.92159943 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.79380273 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.75867396 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.67515188 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.65198925 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.62448586 |
| 20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.60408169 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56545842 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50249468 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.50175631 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.47012773 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46568238 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.46462988 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46400464 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44903377 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40920760 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.39238398 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.39222686 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.36904603 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35368073 |
| 34 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.35042714 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.33904281 |
| 36 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.30884160 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30445774 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.30444069 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30418008 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.28958075 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.28172072 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.27932691 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.27641253 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.27035472 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26267770 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25699314 |
| 47 | Gap junction_Homo sapiens_hsa04540 | 1.21917730 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.18564842 |
| 49 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.18253487 |
| 50 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.15711921 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.14803724 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.14498315 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14477728 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 1.13919781 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.13628284 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13248234 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.12467332 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.11728670 |
| 59 | Long-term depression_Homo sapiens_hsa04730 | 1.11218351 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08469551 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08465023 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07511028 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06723420 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 1.06335721 |
| 65 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04713252 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.04664068 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03036319 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02503074 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02347780 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01884827 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00519457 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00112194 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99493590 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.97915543 |
| 75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94619427 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.93977223 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93882693 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93101577 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90493145 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90484134 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.89787639 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.88627406 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.88367620 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86633828 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86545638 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86286345 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.85208306 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84495253 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.81030484 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80253270 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79633084 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79144757 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.79028714 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77436179 |
| 95 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.77124842 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76156234 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75877268 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75848692 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73074461 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71764124 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70758739 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70056398 |
| 103 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66263327 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65382853 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65179012 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64778733 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64391431 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63353988 |
| 109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62285081 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61769345 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61570884 |
| 112 | Homologous recombination_Homo sapiens_hsa03440 | 0.60694978 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.60504176 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60055485 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59617211 |
| 116 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57873203 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57787048 |
| 118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57313381 |
| 119 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56927141 |
| 120 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56230021 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55655868 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54970742 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.54766890 |
| 124 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53187881 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52492703 |
| 126 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52257684 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52043540 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51812397 |
| 129 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51100486 |
| 130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50760260 |
| 131 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49752864 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49748727 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48166537 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47527993 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46498185 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45510676 |
| 137 | Melanogenesis_Homo sapiens_hsa04916 | 0.45275555 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44966371 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44734920 |
| 140 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42458672 |
| 141 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42258250 |
| 142 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.40749614 |
| 143 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40569888 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40301805 |
| 145 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40257953 |
| 146 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40023376 |
| 147 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38029946 |
| 148 | Prostate cancer_Homo sapiens_hsa05215 | 0.36672087 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36063687 |
| 150 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35666699 |
| 151 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33939409 |
| 152 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32292108 |
| 153 | Ribosome_Homo sapiens_hsa03010 | 0.31412725 |
| 154 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31326064 |
| 155 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31067298 |
| 156 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30660594 |
| 157 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.30617759 |
| 158 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30517671 |
| 159 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29613631 |
| 160 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29490111 |
| 161 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28651817 |
| 162 | Purine metabolism_Homo sapiens_hsa00230 | 0.27867936 |
| 163 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.27286584 |
| 164 | Morphine addiction_Homo sapiens_hsa05032 | 0.27118025 |
| 165 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25953734 |
| 166 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.25810353 |
| 167 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.25673606 |
| 168 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25395907 |
| 169 | GABAergic synapse_Homo sapiens_hsa04727 | 0.24830226 |
| 170 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.23347883 |
| 171 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22532789 |
| 172 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.22325304 |
| 173 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.22119609 |
| 174 | Mineral absorption_Homo sapiens_hsa04978 | 0.21334187 |
| 175 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.20127527 |

